Physician profile
Gabrielle M Grimaldi
NPI 1295224731
$551.38
in general payments reported to CMS, 2019-2025
9 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.81 · 2023: $197 · 2024: $172 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $263.44 | 2022-2025 | Ozempic, Wegovy |
| Silk Road Medical, INC. | $116.05 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Lilly USA, LLC | $63.78 | 2022-2023 | Mounjaro |
| Baxter Healthcare | $23.10 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $18.49 | 2024 | Airsupra |
| Astellas Pharma US INC | $18.12 | 2023 | Veozah |
| Amgen INC. | $16.88 | 2025 | Repatha, Otezla |
| Dexcom, INC. | $15.97 | 2023 | Dexcom G6 Transmitter |
| Seqirus USA INC | $15.55 | 2024 | Fluad, Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabrielle Grimaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.